Mancare Health PVT. LTD.

Mancare Health PVT. LTD. Caring For Humanity

🌍 World AIDS Day β€” December 1β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€œAwareness is the key to prevention”AIDS is a disease of understanding, n...
01/12/2025

🌍 World AIDS Day β€” December 1
β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”β€”

β€œAwareness is the key to prevention”

AIDS is a disease of understanding, not fear.

It is not spread by touching, sitting together, or shaking hands.

It spreads only throughβ€”
β€’ Unprotected s*x
β€’ Contaminated needles
β€’ Lack of proper information

βΈ»

❀️ Prevention is the key to protection

β€’ Maintain safe relationships
β€’ Use clean needles
β€’ Get tested regularly
β€’ Avoid discriminationβ€”not the disease

βΈ»

🌿 A Message of Humanity

People fighting HIV
most of all needβ€”
respect, support, and compassion.

βΈ»

Remember:

Not fearβ€”

Awareness is the key to prevention.

βΈ»

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... TAMSUTATE-D TABLETComposition... Each film coated tablet cont...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...
TAMSUTATE-D
TABLET

Composition...
Each film coated tablet contains: Tamsulosin Hydrochloride IP -0.4mg+ Dutasteride IP-0.5mg + Excipients-q.s.
Tablet

βΈ»

AVEFORD – A Division of Mancare

LAUNCHED NEW PRODUCT

Brand:

TAMSUTATE-D Tablet

(Tamsulosin 0.4 mg + Dutasteride 0.5 mg)

βΈ»

β€” Composition:

Each film-coated tablet contains:
β€’ Tamsulosin Hydrochloride IP β€” 0.4 mg
β€’ Dutasteride IP β€” 0.5 mg
β€’ Excipients β€” q.s.

βΈ»

πŸ“Œ Full Details

πŸ”Ή Description:

TAMSUTATE-D is a combination therapy for Benign Prostatic Hyperplasia (BPH).
It blends two effective agents:
β€’ Tamsulosin – an Alpha-1 blocker that relaxes smooth muscles of the prostate & bladder neck for better urine flow.
β€’ Dutasteride – a 5-Alpha Reductase inhibitor that reduces the size of the enlarged prostate.

Together, they provide faster symptom relief and long-term prostate shrinkage.

βΈ»

πŸ”Ή Indications / Uses:

TAMSUTATE-D is prescribed for men with symptomatic BPH (Enlarged Prostate), especially when both:
β€’ Immediate symptom relief
AND
β€’ Long-term reduction in prostate size

are needed.

It helps reduce:
β€’ Weak urine stream
β€’ Frequent urination
β€’ Nocturia (night-time urination)
β€’ Hesitancy
β€’ Incomplete bladder emptying
β€’ Urinary urgency

βΈ»

πŸ”Ή Mechanism of Action:

Tamsulosin 0.4 mg:
β€’ Blocks alpha-1A receptors
β€’ Relaxes prostate & bladder neck muscles
β€’ Improves urine flow within days

Dutasteride 0.5 mg:
β€’ Blocks both type I and II 5-Alpha Reductase enzymes
β€’ Lowers DHT (dihydrotestosterone)
β€’ Gradually shrinks prostate (3–6 months)

Together they give:
β€’ Fast relief (Tamsulosin)
β€’ Long-term improvement (Dutasteride)

βΈ»

πŸ”Ή Key Features:
β€’ Dual-action therapy for BPH
β€’ Faster symptom control
β€’ Reduces chances of urinary retention
β€’ Decreases risk of needing prostate surgery
β€’ Improves urinary flow & comfort

βΈ»

πŸ”Ή Dosage:

As directed by the physician.
(Usually 1 tablet once daily, after the same meal each day.)

βΈ»

πŸ”Ή Side Effects:

Generally well tolerated. Possible effects include:
β€’ Dizziness
β€’ Ej*******on disorder
β€’ Decreased libido
β€’ Impotence (rare, improves after stopping)
β€’ Breast tenderness (rare)

βΈ»

πŸ”Ή Precautions:
β€’ Not for use in women or children
β€’ Avoid in severe liver disease
β€’ Inform doctor before cataract surgery
β€’ May cause dizziness β†’ avoid driving initially
β€’ Do not donate blood while taking Dutasteride and for 6 months after stopping

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... TAMSUTATE-0.4 TABLETComposition... Each film coated tablet co...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...
TAMSUTATE-0.4
TABLET

Composition...
Each film coated tablet contains: Tamsulosin Hydrochloride IP-0.4mg+ Excipients-q.s.
Tablet

βΈ»

AVEFORD – A Division of Mancare

LAUNCHED NEW PRODUCT

Brand:
TAMSUTATE-0.4 Tablet

βΈ»

β€” Composition:

Each film-coated tablet contains:
β€’ Tamsulosin Hydrochloride IP β€” 0.4 mg
β€’ Excipients β€” q.s.

βΈ»

TAMSUTATE-0.4 Tablet

(Tamsulosin Hydrochloride 0.4 mg)
AVEFORD – A Division of Mancare

βΈ»

πŸ”Ή Description:

TAMSUTATE-0.4 contains Tamsulosin Hydrochloride, a selective alpha-1 adrenergic receptor blocker used to improve urine flow in men with prostate enlargement (BPH).

It relaxes the smooth muscles of the prostate and bladder neck, making urination easier and reducing associated symptoms.

βΈ»

πŸ”Ή Indications / Uses:

TAMSUTATE-0.4 is commonly prescribed for:
β€’ Benign Prostatic Hyperplasia (BPH)
β€’ Weak urine stream
β€’ Difficulty starting urination
β€’ Frequent urination (especially at night)
β€’ Intermittent or incomplete urination
β€’ Urgency with discomfort

βΈ»

πŸ”Ή Mechanism of Action:

Tamsulosin selectively blocks alpha-1A receptors located in the prostate and bladder neck.
This causes:
β€’ Muscle relaxation
β€’ Reduced urinary obstruction
β€’ Improved urine flow
β€’ Relief from BPH symptoms

βΈ»

πŸ”Ή Key Features:
β€’ Highly selective action (fewer side effects)
β€’ Once-daily convenient dosing
β€’ Provides quick relief from urinary symptoms
β€’ Improves quality of life in BPH patients

βΈ»

πŸ”Ή Dosage:

As directed by the physician.
(Usually one tablet once daily, preferably after the same meal each day.)

βΈ»

πŸ”Ή Side Effects:

Generally well tolerated. Possible mild effects:
β€’ Dizziness
β€’ Light-headedness
β€’ Runny nose
β€’ Ej*******on issues (rare)
β€’ Headache

Seek medical advice if symptoms worsen.

βΈ»

πŸ”Ή Precautions:
β€’ May cause dizziness β†’ avoid driving initially
β€’ Inform doctor before cataract surgery (risk of floppy iris syndrome)
β€’ Use cautiously in severe liver disease
β€’ Not recommended for women or children

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... OMIGAS MPS SUSPComposition... Each 10ml contains:- Dried Alum...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...
OMIGAS MPS
SUSP

Composition...
Each 10ml contains:- Dried Aluminium Hydroxide Gel IP-250mg+ Magnesium Hydroxide IP-250mg+ Simethicone IP-50mg+ Sorbitol solution (70%) IP-q.s

βΈ»

AVEFORD – A Division of Mancare

LAUNCHED NEW PRODUCT

Brand:
OMIGAS MPS Suspension

βΈ»
β€” Composition:

Each 10 ml contains:
β€’ Dried Aluminium Hydroxide Gel IP β€” 250 mg
β€’ Magnesium Hydroxide IP β€” 250 mg
β€’ Simethicone IP β€” 50 mg
β€’ Sorbitol Solution (70%) IP β€” q.s.

OMIGAS MPS Suspension

(Antacid + Anti-gas Combination)

πŸ”Ή Description:

OMIGAS MPS is a fast-acting antacid and antiflatulent suspension that neutralizes excess stomach acid and relieves gas, bloating, and abdominal discomfort.

βΈ»

πŸ”Ή Indications / Uses:

It is commonly used for the relief of:
β€’ Acidity / Hyperacidity
β€’ Heartburn
β€’ Sour belching
β€’ Gas, bloating & abdominal discomfort
β€’ Indigestion and upset stomach
β€’ Gastroesophageal reflux symptoms (mild)

βΈ»

πŸ”Ή How It Works:
β€’ Aluminium Hydroxide + Magnesium Hydroxide: Neutralizes excess stomach acid.
β€’ Simethicone: Breaks down gas bubbles to reduce bloating and discomfort.
β€’ Sorbitol: Mild laxative action that helps smooth bowel movement.

βΈ»

πŸ”Ή Key Features:
β€’ Quick relief from acidity & gas
β€’ Gentle on the stomach
β€’ Balanced antacid formulation
β€’ Helps reduce heaviness and discomfort after meals

βΈ»

πŸ”Ή Dosage:

As prescribed by the physician.
(Usually 10–15 ml after meals and at bedtime, but only as directed by doctor.)

βΈ»

πŸ”Ή Side Effects:

Generally well tolerated. Rare possible effects:
β€’ Mild diarrhea or constipation
β€’ Abdominal discomfort
β€’ Nausea (rare)

βΈ»

πŸ”Ή Precautions:
β€’ Not recommended in severe kidney disease unless advised by a doctor
β€’ Keep at least 2 hours gap from other medicines
β€’ Shake well before use

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... FEROMENT-300 ER TABTablet Composition... Each film coated Ext...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...
FEROMENT-300 ER TAB
Tablet

Composition...
Each film coated Extended Release tablet contains:- Faropenem Sodium Hydrate JP equivalent to Faropenem-300mg + Excipients- q.s.
Tablet

βΈ»

FEROMENT-300 ER Tablet

(Faropenem 300 mg – Extended Release)

πŸ”Ή Description:

FEROMENT-300 ER is a broad-spectrum, orally administered carbapenem-class antibiotic designed for extended release, ensuring sustained therapeutic action.

βΈ»

πŸ”Ή Indications / Uses:

It is commonly used in the treatment of:
β€’ Respiratory tract infections
β€’ Skin & soft tissue infections
β€’ Urinary tract infections
β€’ ENT infections
β€’ Gynecological infections
β€’ Post-surgical bacterial infections

βΈ»

πŸ”Ή Key Features:
β€’ Extended Release formulation
β€’ Broad antibacterial coverage
β€’ Better patient compliance (once/twice daily depending on prescription)

βΈ»

πŸ”Ή Dosage:

As directed by the physician (varies by severity and infection type).

βΈ»

πŸ”Ή Side Effects:

Generally well tolerated. Possible mild effects:
β€’ Nausea
β€’ Diarrhea
β€’ Stomach discomfort
β€’ Headache

βΈ»

πŸ”Ή Important Note:

Not to be taken without medical advice. Avoid in cases of known Ξ²-lactam allergy unless prescribed.

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... BETATUS TABTablet Composition... Each uncoated tablet contain...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...

BETATUS TAB
Tablet
Composition...
Each uncoated tablet contains:
Betahistine Dihydrochloride IP-8mg + Excipients-q.s. ( BETATUS - 8 mg)
Tablet
&

Betahistine Dihydrochloride IP-16 mg + Excipients-q.s. ( BETATUS - 16 mg )
Tablet

━━

AVEFORD β€” A Division of MANCARE

⭐ Proudly Announces the Launch of a New ENT / Vertigo Management Product

🌟 BETATUS TABLETS 🌟

Trusted Relief in Vertigo β€’ Meniere’s Disease β€’ Labyrinth Disorders

━━

β€” Available Strengths:

1️⃣ BETATUS – 8 mg Tablet

Composition (Per Uncoated Tablet):
β€’ Betahistine Dihydrochloride IP – 8 mg
β€’ Excipients – q.s.

2️⃣ BETATUS – 16 mg Tablet

Composition (Per Uncoated Tablet):
β€’ Betahistine Dihydrochloride IP – 16 mg
β€’ Excipients – q.s.

━━

πŸ”Ή Indications:

BETATUS is indicated for the management of:
βœ” Vertigo
βœ” Meniere’s Syndrome
βœ” Tinnitus (Ringing in ears)
βœ” Nausea associated with labyrinth disorders
βœ” Hearing disturbances caused by inner-ear imbalance

━━

πŸ”Ή Key Therapeutic Benefits:

βœ” Improves microcirculation in the inner ear
βœ” Reduces the frequency & intensity of vertigo attacks
βœ” Relieves nausea & ear-fullness
βœ” Enhances vestibular compensation
βœ” Well-tolerated with excellent safety profile
βœ” Available in both 8 mg & 16 mg to suit patient requirement

━━

πŸ”Ή Product Positioning:

BETATUS β€” Reliable Betahistine Therapy for Inner Ear Balance & Vertigo Relief.

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... BRUSIC-P 60 ml SYPComposition... Each 5ml Contains:- Ibuprofe...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...
BRUSIC-P
60 ml SYP

Composition...
Each 5ml Contains:- Ibuprofen-100mg + Paracetamol - 162.5mg
60 mL syrup

━━

πŸ“’ AVEFORD β€” A Division of MANCARE

⭐ Proudly Announces the Launch of a New Pediatric Analgesic–Antipyretic

🌟 BRUSIC-P β€” 60 ml SYRUP 🌟

Fast Relief from Fever, Pain & Inflammation (Pediatric Use)

━━

β€” Composition (Per 5 ml):
β€’ Ibuprofen – 100 mg
Non-steroidal anti-inflammatory drug (NSAID)
Reduces pain, inflammation & swelling effectively.
β€’ Paracetamol – 162.5 mg
Trusted antipyretic & analgesic
Rapid relief from fever & mild to moderate pain.

━━━━━━━━━━━━━━━━━━

πŸ”Ή Indications:

For use in:
βœ” Fever (any cause)
βœ” Sore throat, tonsillitis
βœ” Toothache, teething pain
βœ” Post-vaccination fever
βœ” Body ache, ear pain
βœ” Mild inflammation & swelling

━━━━━━━━━━━━━━━━━━

πŸ”Ή Key Advantages:

βœ” Dual action: Anti-inflammatory + Antipyretic + Analgesic
βœ” Better fever control than Paracetamol alone
βœ” Rapid onset & sustained relief
βœ” Safe & well-tolerated pediatric formulation
βœ” Pleasant taste for easy child compliance

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... RUSICARE-K5C 20 gm CREAMComposition... Clobetasol Propionate,...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...
RUSICARE-K5C
20 gm CREAM

Composition...
Clobetasol Propionate, Neomycin Sulphate, Miconazole Nitrate, Glycerin & Cetrimide
20 gm Cream

━━

πŸ“’ AVEFORD β€” A Division of MANCARE

⭐ Proudly Announces the Launch of a New Dermatology Product

🌟 RUSICARE-K5C β€” 20 gm CREAM 🌟

Broad-Spectrum Antifungal β€’ Antibacterial β€’ Anti-inflammatory Healing Cream

━━━━━━━━━━━━━━━━━━

πŸ’Š Composition (Per 20 gm Cream):
β€’ Clobetasol Propionate
Potent anti-inflammatory & anti-allergic steroid for quick relief from redness, itching & swelling.
β€’ Neomycin Sulphate
Powerful antibacterial agent effective against secondary skin infections.
β€’ Miconazole Nitrate
Broad-spectrum antifungal effective against dermatophytes, Candida & Malassezia.
β€’ Glycerin
Moisturizes, repairs and prevents excessive dryness & irritation.
β€’ Cetrimide
Antiseptic & antimicrobial; protects against infection and boosts healing.

━━━━━━━━━━━━━━━━━━

πŸ”Ή Indications:

For the treatment of:
βœ” Fungal skin infections
βœ” Bacterial superinfection
βœ” Eczema, dermatitis & allergic skin reactions
βœ” Redness, itching, rashes
βœ” Infected cuts, minor wounds & inflamed skin lesions

━━━━━━━━━━━━━━━━━━

πŸ”Ή Key Product Benefits:

βœ” Triple-action: Anti-inflammatory + Antibacterial + Antifungal
βœ” Rapid symptomatic relief
βœ” Reduces redness, irritation & itching
βœ” Prevents secondary infection
βœ” Moisturizes & restores the skin barrier
βœ” Ideal for mixed infections & stubborn skin conditions

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... CLINDICARE- 20 TABTablet Composition... Each film coated tabl...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...
CLINDICARE- 20 TAB
Tablet

Composition...
Each film coated tablet contains: Cilndipine IP 20mg + Excipients q.s.
Tablet

━━

AVEFORD β€” A Division of MANCARE

Proudly Announces the Launch of a New Cardiac Product

🌟 CLINDICARE-20 TABLET 🌟

High-Strength Calcium Channel Blocker for Effective BP Control

━━

β€” Composition (Per Film-Coated Tablet):
β€’ Cilnidipine IP – 20 mg
(Dual L-type & N-type Calcium Channel Blocker)
β€’ Excipients – q.s.

━━

πŸ”Ή Indications:

For the treatment and management of:
βœ” Hypertension (High Blood Pressure)
βœ” Patients requiring higher-dose Cilnidipine therapy
βœ” Those who need BP control with reduced sympathetic overactivity

━━

πŸ”Ή Key Advantages:

βœ” Dual L-type + N-type blocking action
βœ” Controls BP without reflex tachycardia
βœ” Reduces sympathetic drive
βœ” Lower chances of ankle edema (vs. Amlodipine)
βœ” Provides vascular relaxation & heart protection
βœ” Effective for moderate to severe hypertension

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... CLINDICARE-T TABTablet Composition... Each film coated tablet...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...
CLINDICARE-T TAB
Tablet

Composition...
Each film coated tablet contains: Telmisartan IP 40mg + Cilndipine IP 10mg + Excipients q.s.
Tablet

━━

AVEFORD β€” A Division of MANCARE

⭐ Proudly Launches a New Anti-Hypertensive Product

🌟 CLINDICARE-T TABLET 🌟

Powerful Dual Action for Effective Blood Pressure Control

━━

Composition (Per Film-Coated Tablet):
β€’ Telmisartan IP – 40 mg
Angiotensin-II receptor blocker (ARB)
Provides 24-hour blood pressure control & cardiovascular protection.
β€’ Cilnidipine IP – 10 mg
Novel L-type + N-type calcium channel blocker
Controls BP + reduces sympathetic overactivity & heart rate load.
β€’ Excipients – q.s.

━━

πŸ”Ή Indications:

For the management of Hypertension (High Blood Pressure), especially beneficial for patients needing:
βœ” 24-hour BP coverage
βœ” Reduced peripheral resistance
βœ” Lower sympathetic activity
βœ” Kidney and heart protection

━━

πŸ”Ή Key Product Benefits:

βœ” Dual mechanism for superior BP control
βœ” ARB + CCB combination with added N-type action
βœ” Minimizes ankle edema (vs. conventional CCBs)
βœ” Provides vascular relaxation & organ protection
βœ” Effective for mild to moderate hypertension

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... GLIMSULIN - MP2 SR TABTablet Composition... Each Uncoated bil...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...
GLIMSULIN - MP2 SR TAB
Tablet

Composition...
Each Uncoated bilayered tablet contains:- Glimepiride IP-2mg + Pioglitazone Hydrochloride IP Equivalent to Pioglitazone-15mg + Metformin Hydrochloride IP -500mg (In Sustained release form) + Excippients
Tablet
β€”β€”

AVEFORD β€” A Division of MANCARE

Proudly Announces the Launch of a New Product

🌟 GLIMSULIN – MP2 SR TABLET 🌟

Advanced Triple Therapy for Type-2 Diabetes Management

━━

πŸ’Š Composition (Per Uncoated Bilayered Tablet):
β€’ Glimepiride IP – 2 mg
Stimulates pancreatic insulin secretion
β€’ Pioglitazone Hydrochloride IP
Equivalent to Pioglitazone – 15 mg
Improves insulin sensitivity & reduces insulin resistance
β€’ Metformin Hydrochloride IP – 500 mg
(Sustained Release Form)
Reduces hepatic glucose output & enhances peripheral uptake
β€’ Excipients – q.s.

━━

πŸ”Ή Indications:

For effective control of Type-2 Diabetes Mellitus, especially in patients requiring:
βœ” Strong sugar control
βœ” Insulin sensitivity improvement
βœ” Reduction in both fasting & post-prandial glucose levels

━━

πŸ”Ή Key Advantages:

βœ” Triple Mechanism – Secretagogue + Sensitizer + Normalizer
βœ” Better glucose utilization
βœ” Improved glycemic index
βœ” SR technology ensures smooth & sustained action
βœ” Ideal for uncontrolled T2DM patients

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCTBrand... GLIMSULIN - MV1 SR TABTablet Composition... Each uncoated tab...
29/11/2025

AVEFORD A DIVISION OF MANCARE LAUNCHED NEW PRODUCT
Brand...
GLIMSULIN - MV1 SR TAB
Tablet

Composition...
Each uncoated tablet contains: Glimepride 1 Mg + Voglibose IP 0.2 Mg + Metformin (SR) HCL IP 500 Mg
Tablet
β€”β€”

AVEFORD – A Division of MANCARE

Proudly Announces the Launch of Its New Product

🌟 GLIMSULIN – MV1 SR TABLET 🌟

A powerful triple-combination for better glycemic control.

━━-

Composition (Per Uncoated Tablet):
β€’ Glimepiride IP – 1 mg
A proven sulfonylurea for insulin release.
β€’ Voglibose IP – 0.2 mg
Delays glucose absorption & controls post-prandial spikes.
β€’ Metformin (SR) HCl IP – 500 mg
First-line insulin sensitizer to improve glucose utilization.

━━

πŸ”Ή Indication:

For the effective management of Type-2 Diabetes Mellitusβ€”
Designed to target Fasting + Post-Prandial + Insulin Resistance in one tablet.

━━

πŸ”Ή Key Benefits:

βœ” Triple mechanism of action
βœ” Better PPBS control
βœ” Improved insulin sensitivity
βœ” Once-daily sustained release convenience
βœ” Ideal for uncontrolled Type-2 DM patients

Address

New Delhi

Telephone

011-45547990

Website

Alerts

Be the first to know and let us send you an email when Mancare Health PVT. LTD. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Mancare Health PVT. LTD.:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category